Cargando…
Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma
SIMPLE SUMMARY: Pediatric sarcomas, including Ewing sarcoma and osteosarcoma, were first to be treated with an anticancer vaccine 100 years ago. This review moves on from a historical perspective to the current progress and challenges of immunotherapy in these immunologically cold bone and soft tiss...
Autores principales: | Evdokimova, Valentina, Gassmann, Hendrik, Radvanyi, Laszlo, Burdach, Stefan E. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818129/ https://www.ncbi.nlm.nih.gov/pubmed/36612267 http://dx.doi.org/10.3390/cancers15010272 |
Ejemplares similares
-
Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function
por: Gassmann, Hendrik, et al.
Publicado: (2021) -
Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma
por: Evola, Francesco R., et al.
Publicado: (2017) -
Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing’s Sarcoma, Enhancing T Cell Cytotoxicity
por: Biele, Emilie, et al.
Publicado: (2021) -
Role of immunotherapy in Ewing sarcoma
por: Morales, Erin, et al.
Publicado: (2020) -
Abnormalities of the FHIT Transcripts in Osteosarcoma and Ewing Sarcoma
por: Hinohara, Shin‐ichi, et al.
Publicado: (1998)